RPRX logo

Royalty Pharma plc (RPRX) Net income

annual net income:

$1.33B-$369.27M(-21.72%)
December 31, 2024

Summary

  • As of today (September 12, 2025), RPRX annual net profit is $1.33 billion, with the most recent change of -$369.27 million (-21.72%) on December 31, 2024.
  • During the last 3 years, RPRX annual net income has risen by +$89.61 million (+7.22%).
  • RPRX annual net income is now -45.93% below its all-time high of $2.46 billion, reached on December 31, 2019.

Performance

RPRX Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXincome statement metrics

quarterly net income:

$90.64M-$342.80M(-79.09%)
June 30, 2025

Summary

  • As of today (September 12, 2025), RPRX quarterly net profit is $90.64 million, with the most recent change of -$342.80 million (-79.09%) on June 30, 2025.
  • Over the past year, RPRX quarterly net income has dropped by -$103.74 million (-53.37%).
  • RPRX quarterly net income is now -93.73% below its all-time high of $1.45 billion, reached on December 31, 2019.

Performance

RPRX quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXincome statement metrics

TTM net income:

$1.66B-$103.74M(-5.87%)
June 30, 2025

Summary

  • As of today (September 12, 2025), RPRX TTM net profit is $1.66 billion, with the most recent change of -$103.74 million (-5.87%) on June 30, 2025.
  • Over the past year, RPRX TTM net income has increased by +$634.25 million (+61.57%).
  • RPRX TTM net income is now -40.17% below its all-time high of $2.78 billion, reached on September 30, 2020.

Performance

RPRX TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXincome statement metrics

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

RPRX Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-21.7%-53.4%+61.6%
3 y3 years+7.2%-81.6%+85.9%
5 y5 years-45.9%-84.9%-35.9%

RPRX Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-21.7%+478.4%-88.8%+114.9%-5.9%+623.4%
5 y5-year-45.9%+478.4%-88.8%+114.9%-40.2%+623.4%
alltimeall time-45.9%+478.4%-93.7%+114.9%-40.2%+623.4%

RPRX Net income History

DateAnnualQuarterlyTTM
Jun 2025
-
$90.64M(-79.1%)
$1.66B(-5.9%)
Mar 2025
-
$433.43M(+29.8%)
$1.77B(+32.9%)
Dec 2024
$1.33B(-21.7%)
$334.00M(-58.6%)
$1.33B(-22.4%)
Sep 2024
-
$806.36M(+314.8%)
$1.71B(+66.4%)
Jun 2024
-
$194.38M(-4649.0%)
$1.03B(-13.2%)
Mar 2024
-
-$4.27M(-100.6%)
$1.19B(-30.2%)
Dec 2023
$1.70B(+639.0%)
$718.00M(+488.2%)
$1.70B(+356.5%)
Sep 2023
-
$122.08M(-65.3%)
$372.50M(-20.9%)
Jun 2023
-
$351.34M(-31.0%)
$470.84M(-23.0%)
Mar 2023
-
$509.09M(-183.5%)
$611.10M(+165.6%)
Dec 2022
$230.06M(-81.5%)
-$610.00M(-376.8%)
$230.09M(-74.3%)
Sep 2022
-
$220.41M(-55.2%)
$894.09M(-0.2%)
Jun 2022
-
$491.60M(+283.8%)
$895.48M(-26.0%)
Mar 2022
-
$128.08M(+137.2%)
$1.21B(-2.5%)
Dec 2021
$1.24B
$54.00M(-75.7%)
$1.24B(-20.1%)
DateAnnualQuarterlyTTM
Sep 2021
-
$221.80M(-72.5%)
$1.55B(-20.6%)
Jun 2021
-
$806.75M(+407.5%)
$1.96B(+11.7%)
Mar 2021
-
$158.98M(-56.7%)
$1.75B(+2.9%)
Dec 2020
$1.70B(-30.9%)
$367.00M(-41.2%)
$1.70B(-38.8%)
Sep 2020
-
$624.25M(+3.7%)
$2.78B(+7.1%)
Jun 2020
-
$601.98M(+451.8%)
$2.60B(+19.5%)
Mar 2020
-
$109.10M(-92.5%)
$2.17B(-11.7%)
Dec 2019
$2.46B(+62.2%)
$1.45B(+228.7%)
$2.46B(+142.5%)
Sep 2019
-
$440.03M(+146.1%)
$1.01B(+76.5%)
Jun 2019
-
$178.77M(-54.9%)
$574.86M(+45.1%)
Mar 2019
-
$396.09M
$396.09M
Dec 2018
$1.52B(+13.0%)
-
-
Dec 2017
$1.34B(+76.3%)
-
-
Dec 2016
$761.89M(+0.4%)
-
-
Dec 2015
$758.71M
-
-

FAQ

  • What is Royalty Pharma plc annual net profit?
  • What is the all time high annual net income for Royalty Pharma plc?
  • What is Royalty Pharma plc annual net income year-on-year change?
  • What is Royalty Pharma plc quarterly net profit?
  • What is the all time high quarterly net income for Royalty Pharma plc?
  • What is Royalty Pharma plc quarterly net income year-on-year change?
  • What is Royalty Pharma plc TTM net profit?
  • What is the all time high TTM net income for Royalty Pharma plc?
  • What is Royalty Pharma plc TTM net income year-on-year change?

What is Royalty Pharma plc annual net profit?

The current annual net income of RPRX is $1.33B

What is the all time high annual net income for Royalty Pharma plc?

Royalty Pharma plc all-time high annual net profit is $2.46B

What is Royalty Pharma plc annual net income year-on-year change?

Over the past year, RPRX annual net profit has changed by -$369.27M (-21.72%)

What is Royalty Pharma plc quarterly net profit?

The current quarterly net income of RPRX is $90.64M

What is the all time high quarterly net income for Royalty Pharma plc?

Royalty Pharma plc all-time high quarterly net profit is $1.45B

What is Royalty Pharma plc quarterly net income year-on-year change?

Over the past year, RPRX quarterly net profit has changed by -$103.74M (-53.37%)

What is Royalty Pharma plc TTM net profit?

The current TTM net income of RPRX is $1.66B

What is the all time high TTM net income for Royalty Pharma plc?

Royalty Pharma plc all-time high TTM net profit is $2.78B

What is Royalty Pharma plc TTM net income year-on-year change?

Over the past year, RPRX TTM net profit has changed by +$634.25M (+61.57%)
On this page